by | Mar 21, 2023 | Publications
Oncologist. 2023 Mar 21:oyad017. doi: 10.1093/oncolo/oyad017. Online ahead of print. ABSTRACT BACKGROUND: Newly diagnosed multiple myeloma patients have many available treatment options. While lenalidomide, bortezomib, and dexamethasone (RVD) is the preferred initial...
by | Mar 21, 2023 | Publications
Nat Med. 2023 Mar 20. doi: 10.1038/s41591-023-02308-5. Online ahead of print. NO ABSTRACT PMID:36941333 | DOI:10.1038/s41591-023-02308-5
by | Mar 21, 2023 | Publications
Lab Med. 2023 Mar 21:lmad012. doi: 10.1093/labmed/lmad012. Online ahead of print. ABSTRACT OBJECTIVE: The acid/molybdate assay performed on the Beckman Coulter AU5821 could be subject to paraprotein interference, which potentially results in spurious...
by | Mar 20, 2023 | Publications
J Clin Oncol. 2023 Mar 20:JCO2202850. doi: 10.1200/JCO.22.02850. Online ahead of print. NO ABSTRACT PMID:36940403 | DOI:10.1200/JCO.22.02850
by | Mar 20, 2023 | Publications
J Clin Oncol. 2023 Mar 20:JCO2202665. doi: 10.1200/JCO.22.02665. Online ahead of print. NO ABSTRACT PMID:36940404 | DOI:10.1200/JCO.22.02665
by | Mar 20, 2023 | Publications
Clin Transl Med. 2023 Mar;13(3):e1224. doi: 10.1002/ctm2.1224. NO ABSTRACT PMID:36938997 | DOI:10.1002/ctm2.1224